Vigil Neuroscience, Inc.
VIGLDelisted Aug 5, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827087
Vigil Neuroscience, Inc. was delisted on Aug 5, 2025; its insiders filed their last Form 4 on Aug 7, 2025; 78 institutions reported holding it in 13F filings for Q2 2025, worth $265.8M in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Vigil Neuroscience, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +7 vs. Q1 2023
- Shares held
- 25.8M
- +700.3K (+2.8%) vs. Q1 2023
- Total value
- $242.1M
- −$3.34M (−1.4%) vs. Q1 2023
- New holders
- 15
- 12 more added
- Sold out
- 8
- 8 more reduced
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VIGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 2 | $4.55K |
| Q2 2025 | 78 | $265.8M |
| Q1 2025 | 50 | $44.5M |
| Q4 2024 | 51 | $38.4M |
| Q3 2024 | 52 | $94.2M |
| Q2 2024 | 58 | $104.5M |
| Q1 2024 | 54 | $90.5M |
| Q4 2023 | 46 | $84.4M |
| Q3 2023 | 45 | $137.7M |
| Q2 2023 | 47 | $242.1M |
| Q1 2023 | 41 | $245.4M |
| Q4 2022 | 37 | $312.3M |
| Q3 2022 | 33 | $222.7M |
| Q2 2022 | 35 | $44.6M |
| Q1 2022 | 47 | $125.1M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Vigil Neuroscience, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,836,874 | $54.9M | 6.83% | 00.0% | Unchanged |
| Northpond Ventures, LLC | 4,214,498 | $39.6M | 65.75% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,180,324 | $20.5M | 0.02% | +18,528+0.9% | Added |
| Deerfield Management Company, L.P. (Series C) | 2,052,010 | $19.3M | 0.41% | 00.0% | Unchanged |
| Artal Group S.A. | 1,911,191 | $18.0M | 0.58% | −332,161−14.8% | Reduced |
| BVF Inc | 1,813,633 | $17.0M | 0.48% | 00.0% | Unchanged |
| Deep Track Capital, LP | 1,773,409 | $16.7M | 0.78% | −251,728−12.4% | Reduced |
| BlackRock Inc. | 821,452 | $7.72M | 0.00% | +719,366+704.7% | Added |
| Vanguard Group Inc | 792,236 | $7.45M | 0.00% | +63,623+8.7% | Added |
| Cormorant Asset Management, LP | 616,786 | $5.80M | 0.33% | 00.0% | Unchanged |
| Pivotal bioVenture Partners Investment Advisor LLC | 560,595 | $5.27M | 1.74% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 471,958 | $4.44M | 0.11% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 448,891 | $4.22M | 0.08% | 00.0% | Unchanged |
| Harvard Management Co Inc | 289,460 | $2.72M | 0.27% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 284,843 | $2.68M | 0.00% | +172,451+153.4% | Added |
| State Street Corp | 259,699 | $2.44M | 0.00% | +223,960+626.7% | Added |
| Trustees of Columbia University in the City of New York | 192,973 | $1.81M | 2.66% | 00.0% | Unchanged |
| Logos Global Management LP | 188,390 | $1.77M | 0.24% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 172,308 | $1.62M | 0.44% | 00.0% | Unchanged |
| FMR LLC | 140,400 | $1.32M | 0.00% | +53,676+61.9% | Added |
| Northern Trust Corp | 124,362 | $1.17M | 0.00% | +102,127+459.3% | Added |
| Barclays PLC | 104,902 | $986.1K | 0.00% | +654+0.6% | Added |
| Laurion Capital Management LP | 99,689 | $937.1K | 0.04% | −30,511−23.4% | Reduced |
| Bank of Montreal | 73,243 | $728.0K | 0.00% | +31,950+77.4% | Added |
| Citigroup Inc | 69,077 | $649.3K | 0.00% | −22,321−24.4% | Reduced |
| Bank of New York Mellon Corp | 48,488 | $455.8K | 0.00% | +48,488 | New |
| Charles Schwab Investment Management Inc | 41,968 | $394.5K | 0.00% | +41,968 | New |
| Nuveen Asset Management, LLC | 24,715 | $232.3K | 0.00% | +24,715 | New |
| Bank of America Corp | 20,133 | $189.3K | 0.00% | +811+4.2% | Added |
| Rhumbline Advisers | 16,358 | $153.8K | 0.00% | +16,358 | New |
| Morgan Stanley | 15,625 | $146.9K | 0.00% | −42,719−73.2% | Reduced |
| PEAK6 Investments LLC | 14,337 | $134.8K | 0.01% | +14,337 | New |
| Goldman Sachs Group Inc | 13,008 | $122.3K | 0.00% | −11,818−47.6% | Reduced |
| JPMorgan Chase & Co | 12,805 | $120.4K | 0.00% | +12,805 | New |
| New York State Common Retirement Fund | 10,000 | $94.0K | 0.00% | +10,000 | New |
| MetLife Investment Management | 9,105 | $85.6K | 0.00% | +9,105 | New |
| American International Group, Inc. | 7,734 | $72.7K | 0.00% | +7,734 | New |
| Wells Fargo & Company | 6,096 | $57.3K | 0.00% | +6,010+6,988.4% | Added |
| California State Teachers Retirement System | 5,345 | $50.2K | 0.00% | +5,345 | New |
| Royal Bank of Canada | 3,499 | $33.0K | 0.00% | +3,499 | New |
| Amalgamated Bank | 1,563 | $15.0K | 0.00% | +1,563 | New |
| Legal & General Group Plc | 1,554 | $14.6K | 0.00% | +1,554 | New |
| Ameritas Investment Partners, Inc. | 1,327 | $12.5K | 0.00% | +1,327 | New |
| Metropolitan Life Insurance Co | 944 | $8.87K | 0.00% | +944 | New |
| Tower Research Capital LLC (TRC) | 625 | $5.88K | 0.00% | −857−57.8% | Reduced |
| State of Wyoming | 143 | $1.34K | 0.00% | +42+41.6% | Added |
| Coppell Advisory Solutions LLC | 2,484 | – | – | −814−24.7% | Reduced |
| Millennium Management LLC | 0 | $0 | 0.00% | −71,381−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −58,718−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −27,184−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −18,705−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −15,092−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | – | Sold out |
| Cannell Capital LLC | 0 | $0 | 0.00% | −8,044−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −592−100.0% | Sold out |
| Coppell Advisory Solutions Corp. | – | – | – | – | Not filed |